This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Request Permissions

A Once-Daily, Oral, Direct Factor Xa Inhibitor, Rivaroxaban (BAY 59-7939), for Thromboprophylaxis After Total Hip Replacement
Circulation Eriksson et al. 114: 2374

Data Supplement

Files in this Data Supplement:

• Appendix and Figure - (Adobe Acrobat PDF) (78.7 KB)

This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Request Permissions